GlassScriptPhysician profile
Mark G Freeman
NPI 1780667865
$83,829.66
in general payments reported to CMS, 2019-2025
37 companies · $663 in 2025
The $663 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49K · 2020: $6,684 · 2021: $3,162 · 2022: $15K · 2023: $8,892 · 2024: $635 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,325 · Food and Beverage: $1,865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,325.00 |
| Food and Beverage | $1,865.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $65,495.71 | 2019-2025 | Real Intelligence, Trigen Intertan, Trigen Meta-Nail |
| Conformis, INC. | $9,775.07 | 2019-2023 | Itotal Hip Replacement System, Actera Hip Stem |
| Steris Corporation | $6,571.67 | 2020 | |
| Orthalign INC | $174.81 | 2019 | |
| Smoky Mountain Surgical LLC | $163.62 | 2023-2024 | |
| Depuy Synthes Sales INC. | $144.73 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $134.77 | 2019-2025 | Euflexxa |
| Linkbio Corp | $118.76 | 2024 | |
| Linvatec Corporation | $101.27 | 2022-2024 | Biobrace 23mm, Hall Power, Linvatec Shoulder Arthroscopy |
| Steris Instrument Management Services, INC. | $100.69 | 2020 | |
| Medacta USA, INC. | $100.28 | 2023-2024 | Gmk Sphere |
| Innovation Technologies INC | $88.46 | 2021 | |
| Paragon 28, INC. | $82.69 | 2022 | |
| Restor3d, INC. | $72.51 | 2023 | |
| Globus Medical, INC. | $70.60 | 2023 | Distal Femur Plate System |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $66.39 | 2023-2024 | Iovera, Zilretta, Exparel |
| Medtronic, INC. | $58.10 | 2021-2025 | Osteocool Rf Ablation System, Plasmablade(Tm) |
| Organogenesis INC. | $53.05 | 2024 | Affinity |
| Zimmer Biomet Holdings, INC. | $43.60 | 2019-2024 | |
| Pacira Therapeutics, INC. | $40.35 | 2019-2021 | |
| Trice Medical, INC. | $35.15 | 2023 | |
| Medical Device Business Services, INC. | $32.17 | 2022 | |
| Heron Therapeutics, INC. | $27.63 | 2024 | Zynrelef |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $27.20 | 2024 | |
| Djo, LLC | $25.91 | 2025 | Cmf |
| Anika Therapeutics, INC. | $24.51 | 2025 | Integrity Implant |
| Acera Surgical, INC. | $24.25 | 2025 | Restrata Wound Matrix |
| Nalu Medical, INC. | $24.05 | 2023 | Nalu Neurostimulation System |
| Alpha Orthopedic Systems | $23.57 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $20.37 | 2023 | Seglentis |
| Sanofi-Aventis U.S. LLC | $19.94 | 2019 | |
| Kci USA, INC. | $17.79 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.95 | 2023 | Andexxa |
| Ethicon US, LLC | $15.38 | 2023 | Ethicon |
| Abbvie INC. | $15.26 | 2023 | |
| Horizon Therapeutics Plc | $11.73 | 2019 | |
| Allergan, INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.